240 related articles for article (PubMed ID: 26956561)
1. Clear cell atypical fibroxanthoma: a case report and review of the literature.
Nguyen CM; Chong K; Cassarino D
J Cutan Pathol; 2016 Jun; 43(6):538-542. PubMed ID: 26956561
[TBL] [Abstract][Full Text] [Related]
2. Clear cell atypical fibroxantoma: a rare variant of atypical fibroxanthoma and review of the literature.
Bedir R; Agirbas S; Sehitoglu I; Yurdakul C; Elmas O
J Clin Diagn Res; 2014 Jun; 8(6):FD09-11. PubMed ID: 25120992
[TBL] [Abstract][Full Text] [Related]
3. Clear cell atypical fibroxanthoma - report of a case with review of the literature.
Murali R; Palfreeman S
J Cutan Pathol; 2006 May; 33(5):343-8. PubMed ID: 16640540
[TBL] [Abstract][Full Text] [Related]
4. Clear cell atypical fibroxanthoma:a clinicopathologic study.
Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
6. Myxoid atypical fibroxanthoma: a previously undescribed variant.
Patton A; Page R; Googe PB; King R
J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
[TBL] [Abstract][Full Text] [Related]
7. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
8. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
Buonaccorsi JN; Plaza JA
Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
[TBL] [Abstract][Full Text] [Related]
9. An Atypical Fibroxanthoma and Intradermal Nevus Collision Tumor-Potential for Misdiagnosis.
Steel A; Debbaneh M; Cassarino D
Am J Dermatopathol; 2019 Aug; 41(8):e87-e89. PubMed ID: 31335430
[TBL] [Abstract][Full Text] [Related]
10. Sarcoma-like tumor of head and neck skin.
Nonaka D; Bishop PW
Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
[TBL] [Abstract][Full Text] [Related]
11. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
Wieland CN; Dyck R; Weenig RH; Comfere NI
J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
[TBL] [Abstract][Full Text] [Related]
12. Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature With Special Emphasis on the Differential Diagnosis.
Tardío JC; Pinedo F; Aramburu JA; Martínez-González MÁ; Arias D; Khedaoui R; Suárez-Massa D; Santonja C
Am J Dermatopathol; 2016 Aug; 38(8):586-92. PubMed ID: 26848640
[TBL] [Abstract][Full Text] [Related]
13. Atypical Fibroxanthoma: A case series and review of literature.
Mahalingam S; Shah A; Stewart A
Auris Nasus Larynx; 2015 Dec; 42(6):469-71. PubMed ID: 25912604
[TBL] [Abstract][Full Text] [Related]
14. Atypical fibroxanthoma in a young female misdiagnosed clinically as a malignant melanoma--An unusual presentation.
Pujani M; Hassan MJ; Jetley S
J Cancer Res Ther; 2015; 11(4):1027. PubMed ID: 26881598
[TBL] [Abstract][Full Text] [Related]
15. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
16. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
Miller K; Goodlad JR; Brenn T
Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
[TBL] [Abstract][Full Text] [Related]
18. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
[TBL] [Abstract][Full Text] [Related]
20. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
